Biogen Idec reported a higher-than-expected second-quarter profit on Tuesday as sales of its closely watched multiple sclerosis drug Tysabri surged past Wall Street estimates.
Biogen Idec reported a higher-than-expected second-quarter profit on Tuesday as sales of its closely watched multiple sclerosis drug Tysabri surged past Wall Street estimates. Discussion
Biogen Idec reported a higher-than-expected second-quarter profit on Tuesday as sales of its closely watched multiple sclerosis drug Tysabri surged past Wall Street estimates. ... Discussion
Earthtimes (press release)Tiffany Profit Surpasses Analysts Estimates on Overseas SalesBloomberg - 58 minutes agoBy Cotten Timberlake Full-year profit will be $2.80 to $2 ... Discussion
Mobile phone company to use photo-sharing service ... EBay profit surpasses Wall Street estimates ... IBM quarterly profit rises 26 percent, beats forecasts Discussion
Wyeth said earnings fell 7 percent, hurt by generic forms of its Protonix ulcer drug, although results beat estimates. Discussion
Research firm comScore Inc. reports its second-quarter profit and sales generally beat Wall Street analysts' estimates, helping send the company's shares sharply higher in lat ... Discussion
Barr, which has agreed to be bought by Teva Pharmaceutical Industries, posted higher-than-expected quarterly profit on strong sales of its oral contraceptives and brand-name p ... Discussion
Reuters - Wyeth on Wednesday said
second-quarter earnings fell 7 percent, hurt by generic forms
of its Protonix ulcer drug, although results beat estimates as
they were he ... Discussion
CNBCUPDATE: Amgen 2Q Profit Beats Street On Anemia Drug SalesCNNMoney.com - 32 minutes agoNEW YORK -(Dow Jones)- Amgen Inc.s (AMGN) second-quarter profit dropped 7.7% but ... Discussion
Wall Street JournalLowes Profit Beats Estimates as Tax Rebates Spent (Update1)Bloomberg - 35 minutes agoBy Mark Clothier Aug. 18 (Bloomberg) -- Lowes Cos., the worlds sec ... Discussion
